Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
Open accessThe DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) comprises fat-accumulating conditions within hepatocytes that can cause severe liver damage and metabolic comorbidities. Studies suggest that mitochondrial dysfunction contributes to its development and progression and that the hepatic lipidome changes extensively in obesity and in NAFLD. To gain insight into the relationship between lipid metabolism and disease progression through different stages of NAFLD, we performed lipidomic analysis of plasma and liver biopsy samples from obese patients with nonalcoholic fatty liver (NAFL) or nonalcoholic steatohepatitis (NASH) and from those without NAFLD. Congruent with earlier studies, hepatic lipid levels overall increased with NAFLD. Lipid species that differed with NAFLD severity were related to mitochondrial dysfunction; specifically, hepatic cardiolipin and ubiquinone accumulated in NAFL, and levels of acylcarnitine increased with NASH. We propose that increased levels of cardiolipin and ubiquinone may help to preserve mitochondrial function in early NAFLD, but that mitochondrial function eventually fails with progression to NASH, leading to increased acylcarnitine. We also found a negative association between hepatic odd-chain phosphatidylcholine and NAFLD, which may result from mitochondrial dysfunction-related impairment of branched-chain amino acid catabolism. Overall, these data suggest a close link between accumulation of specific hepatic lipid species, mitochondrial dysfunction, and the progression of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ceramides are among the most studied lipids because of their lipotoxic activity in several organs and have been reported to be increased in the plasma of patients with MASLD.94,[99], [100], [101], [102],[107], [108], [109],115”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [99]
In the citing paper
“Peng et al.99 showed that TAGs, DAGs, ceramides, PE, lysophosphatidylethanolamine and cholesterol esters were significantly increased, and PC and LPC significantly reduced, in MASH vs. controls (Table 1).”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 1×
“In the current study, we found increased hepatic levels of TG, DG, CE, and free cholesterol in individuals with NAFLD, which is in congruence with earlier studies (19, 20).”
ResultKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
Cardiolipin Stabilizes Respiratory Chain Supercomplexes
Pfeiffer, K., Gohil, V., Stuart, R. A., Hunte, C., Brandt, U., Greenberg, M. L., & Schägger, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308366200 · Cited by 843 · cited 1×
“Cardiolipin is also important for mitochondrial biogenesis and the assembly of respiratory enzyme supercomplexes (25).”
BackgroundMitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 1×
“Mitochondrial dysfunction has been suggested to play a pivotal role in the pathogenesis of NAFLD (13, 14).”
BackgroundDefective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003) · Hepatology · doi:10.1002/hep.1840380426 · Cited by 734
ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700
The plasma lipidomic signature of nonalcoholic steatohepatitis
Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655
Role of cardiolipin alterations in mitochondrial dysfunction and disease
Chicco, A. J., & Sparagna, G. C. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00243.2006 · Cited by 642
Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
Self-citationSchooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616
Forouhi, N. G., Koulman, A., Sharp, S. J., Imamura, F., Kröger, J., Schulze, M. B., Crowe, F. L., Huerta, J. M., Guevara, M., Beulens, J. W., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70146-9 · Cited by 557
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease
Paradies, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14205 · Cited by 500
Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis
Green, C. R., Wallace, M., Divakaruni, A. S., Phillips, S. A., Murphy, A. N., Ciaraldi, T. P., & Metallo, C. M. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1961 · Cited by 471 · cited 1×
“, valine, leucine, and isoleucine) (40, 41).”
Schlame, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r700018-jlr200 · Cited by 388
Paradies, G., Petrosillo, G., Pistolese, M., & Ruggiero, F. M. (2002) · Gene · doi:10.1016/s0378-1119(01)00814-9 · Cited by 372
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Gorden, D. L., Myers, D. S., Ivanova, P. T., Fahy, E., Maurya, M. R., Gupta, S., Min, J., Spann, N. J., McDonald, J. G., Kelly, S. L., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p056002 · Cited by 372
Plasma lipid profiling in a large population-based cohort
Weir, J. M., Wong, G., Barlow, C. K., Greeve, M. A., Kowalczyk, A., Almasy, L., Comuzzie, A. G., Mahaney, M. C., Jowett, J. B. M., Shaw, J., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p035808 · Cited by 366 · cited 1×
“Targeted lipidomics for the liver and plasma specimens was performed using LC coupled with an electrospray ionization Qtrap 4000 mass spectrometer (AB Sciex), as described earlier with slight modifications (10).”
MethodSelf-citationHsu, F.-F., & Turk, J. (2003) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(03)00064-3 · Cited by 332
Biochemistry of Mitochondrial Coenzyme Q Biosynthesis
Stefely, J. A., & Pagliarini, D. J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.06.008 · Cited by 331
Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease
Meikle, P. J., Wong, G., Tsorotes, D., Barlow, C. K., Weir, J. M., Christopher, M. J., MacIntosh, G. L., Goudey, B., Stern, L., Kowalczyk, A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234096 · Cited by 306
Self-citationRole of ceramides in nonalcoholic fatty liver disease
Pagadala, M., Kasumov, T., McCullough, A. J., Zein, N. N., & Kirwan, J. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.04.005 · Cited by 303
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1318 · Cited by 284
Molecular symmetry in mitochondrial cardiolipins
Schlame, M., Ren, M., Xu, Y., Greenberg, M. L., & Haller, I. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.08.002 · Cited by 278
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N. S., & Cheng, S. H. (2007) · Diabetes · doi:10.2337/db06-0719 · Cited by 238
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D. G., Reily, M. D., Lehman-McKeeman, L. D., Vaillancourt, R. R., & Cherrington, N. J. (2015) · Amino Acids · doi:10.1007/s00726-014-1894-9 · Cited by 232
Petrosillo, G., Ruggiero, F. M., Pistolese, M., & Paradies, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03206-9 · Cited by 224
Crown, S. B., Marze, N., & Antoniewicz, M. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145850 · Cited by 197 · cited 1×
“, valine, leucine, and isoleucine) (40, 41).”
Lefort, N., Glancy, B., Bowen, B., Willis, W. T., Bailowitz, Z., De Filippis, E. A., Brophy, C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db10-0174 · Cited by 174
The enigmatic role of tafazzin in cardiolipin metabolism
Houtkooper, R. H., Turkenburg, M., Poll‐The, B. T., Karall, D., Pérez‐Cerdá, C., Morrone, A., Malvagia, S., Wanders, R. J. A., Kulik, W., & Vaz, F. M. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.07.009 · Cited by 168
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
Patterson, R. E., Kalavalapalli, S., Williams, C. M., Nautiyal, M., Mathew, J. T., Martinez, J., Reinhard, M. K., McDougall, D. J., Rocca, J. R., Yost, R. A., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2015 · Cited by 161
Mitochondrial Roles and Cytoprotection in Chronic Liver Injury
Degli Esposti, D., Hamelin, J., Bosselut, N., Saffroy, R., Sebagh, M., Pommier, A., Martel, C., & Lemoine, A. (2012) · Biochemistry Research International · doi:10.1155/2012/387626 · Cited by 158 · cited 1×
“4,000 mitochondria per hepatocyte) (22), and mitochondrial abnormalities associated with NAFLD include abnormal morphological changes, leaking mitochondria, and oxida-”
BackgroundNonalcoholic fatty liver disease as a multi-systemic disease
Fotbolcu, H., & Zorlu, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i16.4079 · Cited by 145 · cited 1×
“Given that the liver is a central regulator of whole-body energy homeostasis, it is not surprising that many individuals with NAFLD are also characterized by metabolic complications, including insulin resistance, muscle atrophy, and cardiovascular disease, resulting in increased morbidity and mortality (3).”
BackgroundGoffredo, M., Santoro, N., Tricò, D., Giannini, C., D’Adamo, E., Zhao, H., Peng, G., Yu, X., Lam, T. T., Pierpont, B. M., et al. (2017) · Nutrients · doi:10.3390/nu9070642 · Cited by 138
Kaikkonen, J. E., Würtz, P., Suomela, E., Lehtovirta, M., Kangas, A. J., Jula, A., Mikkilä, V., Viikari, J. S. A., Juonala, M., Rönnemaa, T., et al. (2017) · Hepatology · doi:10.1002/hep.28899 · Cited by 122
Hsu, F., TURK, J. W., Thukkani, A. K., Messner, M. C., Wildsmith, K. R., & Ford, D. A. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.491 · Cited by 116
Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity
Anjani, K., Lhomme, M., Sokolovska, N., Poitou, C., Aron-Wisnewsky, J., Bouillot, J.-L., Lesnik, P., Bedossa, P., Kontush, A., Clement, K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.002 · Cited by 106
Su, X., Magkos, F., Zhou, D., Eagon, J. C., Fabbrini, E., Okunade, A. L., & Klein, S. (2014) · Obesity · doi:10.1002/oby.20923 · Cited by 95
Bijl, N., Sokolović, M., Vrins, C. L. J., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 95
Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
Rodríguez‐Cuenca, S., Barbarroja, N., & Vidal‐Puig, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.021 · Cited by 92
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #
Zhao, H., Przybylska, M., Wu, I., Zhang, J., Maniatis, P., Pacheco, J., Piepenhagen, P. A., Copeland, D., ARBEENY, C. M., Shayman, J. A., et al. (2009) · Hepatology · doi:10.1002/hep.22970 · Cited by 90
Cardiolipin promotes electron transport between ubiquinone and complex I to rescue PINK1 deficiency
Vos, M. H., Geens, A., Böhm, C., Deaulmerie, L., Swerts, J., Rossi, M., Craessaerts, K., Leites, E. P., Seibler, P., Raković, A., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201511044 · Cited by 88
Aoun, M., Fouret, G., Michel, F., Bonafos, B., Ramos, J., Cristol, J., Carbonneau, M., Coudray, C., & Feillet‐Coudray, C. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9448-x · Cited by 75
Ferreira, F. M. L., Seiça, R. M. F., Oliveira, P. J., Coxito, P. M., Moreno, A. J., Palmeira, C. M., & Santos, M. S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.08.001 · Cited by 61 · cited 2×
“(28) also observed increased levels of hepatic cardiolipin and ubiquinone in two diabetic rat models (Goto-Kakizaki and STZ-induced).”
BackgroundSchwenger, K. J. P., Fischer, S. E., Jackson, T. D., Okrainec, A., & Allard, J. P. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2980-3 · Cited by 55 · cited 1×
“NAFLD is the predominant cause of chronic liver disease in many parts of the world, and is present in 75–90% of adults who are morbidly obese (1, 2).”
BackgroundMeikle, P. J., Mundra, P. A., Wong, G., Rahman, K., Huynh, K., Barlow, C. K., Duly, A. M. P., Haber, P., Whitfield, J. B., & Seth, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130346 · Cited by 45
Self-citationLee, A. Y., Lee, J. W., Kim, J., Mok, H. J., Park, S. J., Kim, S., Hong, S., Kim, J., Park, E., Kang, K., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.110 · Cited by 45
Fouret, G., Gaillet, S., Lecomte, J., Bonafos, B., Djohan, Y. F., Baréa, B., Badia, É., Coudray, C., & Feillet‐Coudray, C. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003713 · Cited by 32
Sa, R., Zhang, W., Ge, J., Wei, X., Zhou, Y., Landzberg, D. R., Wang, Z., Han, X., Chen, L., & Yin, H. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw016 · Cited by 29
Botham, K. M., Napolitano, M., & Bravo, E. (2015) · Nutrients · doi:10.3390/nu7125501 · Cited by 19
Kulkarni, H. R., Meikle, P. J., Mamtani, M., Weir, J. M., Barlow, C. K., Jowett, J. B. M., Bellis, C., Dyer, T. D., Johnson, M. P., Rainwater, D. L., et al. (2013) · Lipids · doi:10.1007/s11745-013-3781-7 · Cited by 18
Self-citationOKADA, Y., Arima, T., Hada, H., FUKUSHIMA, M., Watanabe, J., & Nagashima, H. (1985) · Liver International · doi:10.1111/j.1600-0676.1985.tb00242.x · Cited by 11
Cited by
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Self-citationHow does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 432
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
Hodson, L., & Gunn, P. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0256-9 · Cited by 309
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease
Puchalska, P., & Crawford, P. A. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-111120-111518 · Cited by 282
Emami, N. K., Jung, U., Voy, B., & Dridi, S. (2020) · Antioxidants · doi:10.3390/antiox10010035 · Cited by 247
Metadata
- Authors
- Peng, K.-Y., Watt, M. J., Rensen, S., Greve, J. W., Huynh, K., Jayawardana, K. S., Meikle, P. J., & Meex, R. C. R.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- The University of Melbourne (AU)
- Maastricht University Medical Centre (NL)
- Zuyderland Medisch Centrum (NL)
- Corresponding author
- Meikle, Peter J.
- Meex, Ruth C.R.
- ORCID
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 59
- Issue
- 10
- Pages
- 1977-1986
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC6168306
- OpenAlex
- W2884907724
- Cited by
- 220
- References
- 57
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 33 · 2023: 39 · 2022: 25 · 2021: 43 · 2020: 27 · 2019: 13 · 2018: 2
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 708 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Health and Medical Research Council (APP1061278, APP1077703, APP1042095)
- University of Melbourne
- H2020 Marie Skłodowska-Curie Actions (H2020-MSCA-IF)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, mitochondrial dysfunction, hepatic lipidome, cardiolipin, coenzyme Q10, acylcarnitines, branched-chain amino acid catabolism, disease progression, obesity, plasma lipidomics, liver biopsy
- MeSH terms
- Adult, Female, Humans, Liver, Male, Middle Aged, Mitochondria, Cohort Studies, Disease Progression, Lipid Metabolism, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.